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10
11 Dear Editor,
12
13 We read with interest the article by Gifford et al. “Iron
14 supplementation does not worsen respiratory health or alter the
15 sputum microbiome in cystic fibrosis”, published in the Journal
16 of Cystic Fibrosis [1]. In this double-blind cross-over randomised
17 placebo-controlled trial, the authors show that 6 weeks of oral
18 iron supplementation does not worsen respiratory health but fail
19 to correct anaemia. This is in contrast to our earlier report that
20 intravenous iron improves haemoglobin but may carry the risk of
21 worsening respiratory infection [2].
22 One reason for this contrast is the different routes of iron
23 supplementation. Hepcidin is an antimicrobial-like peptide
24 hormone synthesised by the liver that acts as the ‘master
25 regulator’ of iron metabolism [3]. Hepcidin level increases after
26 acute administration of oral iron supplementation to reduce
27 duodenal iron absorption and sequester iron in the reticuloendo-
28 thelial system [3,4]. This is a protective mechanism to protect
29 against infection, since most human pathogens are iron dependent
30 [3]. Intravenous iron may overwhelm iron withholding mecha-
31 nisms, increase lung iron content and increase susceptibility to
32 infection.
33 Another reason for this contrast is that every patient in our
34 case series received standard treatment for CF exacerbation [2].
35 Since our report was published, other reports in the Journal
36 of Cystic Fibrosis have highlighted that intravenous antibiotics
37 may improve haemoglobin [5,6]. Gifford et al. demonstrated
38significant improvement in participants' serum iron level even
39with low dose oral iron and high serum hepcidin-25 concentra-
40tions [1]. Therefore, improving serum iron level alone may not be
41enough to improve haemoglobin level among people with CF.
42Interleukin-6 (IL-6) is abundant in the blood of people with CF
43[7]. IL-6 represses erythropoietin-dependent maturation of
44erythroid cell lines and limits haemoglobin synthesis [8]. IL-6
45levels fall during the treatment of CF exacerbation [7], which
46may explain the improvement in haemoglobin.
47Another report in the Journal of Cystic Fibrosis has highlighted
48the importance of accurately assessing systemic iron status to
49avoid injudicious iron supplementation [9]. There may be a risk of
50respiratory deterioration if oral iron supplementation is continued
51after the subject has become iron replete, which is not assessed in
52Gifford et al.'s short (6-week) study [1].
53Iron deficiency anaemia remains an important clinical
54issue for people with CF and further studies on its optimal
55management are needed. Gifford et al. suggested that a larger
56randomised controlled trial is needed to demonstrate the safety
57of oral iron [1]. We suggest that a similar trial of intravenous
58iron is also needed.
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